New Mark and Mitelos agree to market the therapeutic alternative for treating impacted ear wax OTIBLOCK® otic spray in the markets of the United Arab Emirates and Saudi Arabia


June 13, 2017.- OTIBLOCK® otic spray helps to remove impacted ear wax from the ear canal thanks to its formulation, which is oil-free and helps the ear to maintain the proper pH. OTIBLOCK®, developed by Mitelos, is due to go on sale by New Mark in the mentioned markets.

Through this agreement for the UAE and Saudi Arabia, New Mark will add yet another product to its ENT portfolio, a specialty in which it has significant commercial activity.  Additionally, with this deal Mitelos has achieved

an important milestone opening new markets for OTIBLOCK® in Middle East. Caring for the ears is essential to prevent hearing problems and other symptoms. It is estimated that one in twenty adults at some point in their life will experience impacted ear wax. This figure rises to one in three people in the elderly population.

In addition to its cerumenolytic action, OTIBLOCK® benefits patients with associated risk factors that make them more prone to otitis externa, such as those with dermatological conditions (eczema, psoriasis, seborrheic dermatitis, etc.) and immunosuppression, and users of headphones and hearing aids.

The product is already sold in the Spanish market since last September where in a few months has gained a double-digit market share.

OTIBLOCK® comes in a 45-mL dosage form, including an ergonomic, push-button otic spray, which enables the correct and convenient self-administration by the patient.

About New Mark Medicine Trading

Established in 2010 in Dubai, New Mark is a success story in the UAE market. The business  started in 1995, with a group of Pharmacies. New Mark focuses on high quality unique products ranging from OTC, pharmaceuticals, and Medical Equipment.  We take a direct approach networking face to face with Physicians and Pharmacists in over 85 Hospitals and 400 clinics in the UAE, including public and private facilities.

For more information, visit

+971 4 5546920 

About Mitelos

Established in 2013 in Barcelona, Mitelos is an independent private company that develops, registers and manufactures medical devices and dietary supplements. Mitelos also provides business development services to third parties in order to help clients achieve their growth-related goals.

For more information, visit

Tel.: +34 935 481 858